
doi: 10.1007/bf01922968
pmid: 720532
Adenine-arabinoside, a new antiviral drug with questionable bone marrow toxicity, inhibits colony formation by myeloid precursor cells in vitro. Compared to cytosine-arabinoside this cytotoxicity is roughly one third.
Dose-Response Relationship, Drug, Bone Marrow, Cell Survival, Cytarabine, Humans, Cell Division, Cells, Cultured, Vidarabine
Dose-Response Relationship, Drug, Bone Marrow, Cell Survival, Cytarabine, Humans, Cell Division, Cells, Cultured, Vidarabine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
